Dynavax (DVAX) Reports DV1179 Did Not Meet Endpoints in Phase 1b/2a
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Dynavax Technologies Corp (DVAX) Posts Mixed Q2 Results
August 7, 2014 6:27 AM EDTDynavax Technologies Corp (NASDAQ: DVAX) reported Q2 EPS of ($0.09), $0.03 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $3.05 million versus the consensus estimate of $2.26 million.
For earnings history and earnings-related data on Dynavax Technologies Corp (DVAX) click here.
... More